Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors
- PMID: 9618311
- DOI: 10.1006/bbrc.1998.8726
Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors
Abstract
We have generated an adenovirus containing a retroviral vector sequence encoding the neomycin phosphotransferase (neo) gene (AV-LXSN). AV-LXSN transduction of retroviral packaging cell lines led to production of LXSN retroviral vector with alternative viral envelopes; exposure of target cells to retroviral containing supernatants confirmed envelope specific tropism. Retroviral titers (G418 cfu/ml) were comparable to those produced by standard techniques. Retrovirus could be detected in supernatants within 24 hours of AV-LXSN transduction and persisted as long as 120 hours. Southern blot analysis of DNA purified from populations of G418 cells showed the presence of a single neo containing restriction fragment of the appropriate size that could only be generated by reverse transcription of LXSN to produce LXSN provirus. This adeno-retroviral chimeric vector system could simplify the generation and testing of different retroviral vectors, particularly where assessment of vectors with alternative envelopes carrying novel targeting ligands is required.
Similar articles
-
Adeno-retroviral chimeric viruses as in vivo transducing agents.Gene Ther. 1999 Mar;6(3):454-9. doi: 10.1038/sj.gt.3300835. Gene Ther. 1999. PMID: 10435096
-
In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.J Gene Med. 2004 Mar;6(3):288-99. doi: 10.1002/jgm.490. J Gene Med. 2004. PMID: 15026990
-
Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.Gene Ther. 1996 Sep;3(9):780-8. Gene Ther. 1996. PMID: 8875226
-
Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.Gene Ther. 2005 Jul;12(14):1089-98. doi: 10.1038/sj.gt.3302570. Gene Ther. 2005. PMID: 16003340 Review.
-
[Gene therapy vector: retroviral vector].Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1789-97. Tanpakushitsu Kakusan Koso. 1997. PMID: 9279114 Review. Japanese. No abstract available.
Cited by
-
Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism.Autophagy. 2015 Apr 3;11(4):685-700. doi: 10.4161/auto.36098. Autophagy. 2015. PMID: 25484089 Free PMC article.
-
Identification of gene function by cyclical packaging rescue of retroviral cDNA libraries.Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8838-43. doi: 10.1073/pnas.132274799. Proc Natl Acad Sci U S A. 2002. PMID: 12084928 Free PMC article.
-
A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.PLoS One. 2013 Oct 9;8(10):e75574. doi: 10.1371/journal.pone.0075574. eCollection 2013. PLoS One. 2013. PMID: 24130722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources